Introduction {#S0001}
============

One of the most important advances in regulatory toxicology has been the implementation of the Globally Harmonised System (GHS) for the identification, classification and labelling of substances, mixtures and preparations (United Nations-Economic Commission for Europe, [@CIT0025]). The hazard associated with a single chemical substance or a mixture of 2 or more substances refers to their intrinsic property to cause a particular effect, in this case, acute skin irritation and corrosion. In regulatory terms, skin corrosion represents irreversible damage to the skin, whereas skin irritation is characterised by clinical evidence of inflammation which is entirely reversible.

In the past, the potential of a substance or preparation to cause skin irritation or corrosion had been assessed using a rabbit skin test (Draize *et al.*, [@CIT0010]; Draize [@CIT0011]). However, *in vitro* alternatives have now taken the place of the rabbit test and in a similar manner aim at a basic hazard identification of chemicals which can cause burns or a significant level of acute skin irritation (ECHA, [@CIT0013]; Eskes *et al.*, [@CIT0014]; Commission Regulation, [@CIT0009]). These efforts in regulatory toxicology are directed towards characterisation of the intrinsic properties of substances, with subsequent application of that knowledge to mixtures and formulations. Hazard information from human studies is unfortunatley not available, since due to ethical reasons, testing in humans for clasification and labelling purposes is not accepted.

In the clinics, reports on acute skin irritation are rare; skin corrosion (chemical burns) do occur, but even so, the actual exposure is often hard to characterise. Utimately nevertheless, the value of any piece of toxicological work is the prediction of effects seen in exposed human population. To obtain controlled human acute skin irritation information, an alternative strategy involving a protocol for the use of human volunteers, the 4 h Human Patch Test (4 h HPT), to characterize skin irritation hazard has been developed and described extensively in the literature (Basketter, [@CIT0001]; Basketter *et al.* [@CIT0002], [@CIT0003]; [@CIT0006]; York *et al.* [@CIT0027]; Robinson *et al.*, [@CIT0022]).

The 4 h HPT provides the opportunity to identify substances with significant skin irritation potential without recourse to the use of animals. It can be applied for the evaluation skin effects of single substances as well as mixtures and formulations (Robinson *et al.*, [@CIT0021]). The human skin irritation test is very similar to the regulatory accepted *in vivo* rabbit skin irritation test, but it is designed to limit the intensity of skin reactions in human volunteers. The value of the method is in 1) providing data for the identification of those substances or formulation which should or should not be classified as irritant, and 2) providing "gold standard" data for future validations of alternative/*in vitro* methods replacing the *in vivo* rabbit test for classification and labelling purposes in regulatory toxicology.

In the material that follows, the literature has been surveyed to permit the assembly of an extended catalogue of substances to which human subjects have been exposed using the 4 h HPT protocol. Only on very few occasions, substances appeared to possess a greater ability to generate irritant skin reactions than had been expected. More importantly, many more substances had only a very limited effect on skin. Consequently, it is essential that new *in vitro* toxicology tests are calibrated and whenever possible validated against human data rather than use information from *in vivo* rabbit assays obtained usually from outdated databases.

Material and methods {#S0002}
====================

The 4 h human patch test -- protocol {#S20003}
------------------------------------

The human 4 h patch test has been described in complete detail in the literature (Basketter *et al.* [@CIT0002], [@CIT0006]; York *et al.*, [@CIT0027]; Robinson *et al.*, [@CIT0022], [@CIT0021]). Briefly, the human patch test procedure involves application of 0.2 ml (0.2g for solid test materials) on a 25 mm plain Hill Top Chamber containing a Webril pad (Hill Top Companies, Cincinnati, Ohio, USA), moistened for solid test materials, to the skin of the upper outer arm of 30 human volunteers for up to 4 hours.

To avoid the production of unacceptably strong reactions, test materials are applied progressively from 15 and 30 minutes through 1, 2, 3 and 4 h. Each progressive application is at a new skin site. The shorter exposure periods can be omitted if the study directors are satisfied that excessive reactions will not occur following longer exposure. Treatment sites are assessed for the presence of irritation at 24, 48 and 72h after patch removal. A volunteer with a reaction at any of the assessments is considered to have demonstrated a "positive" irritant reaction and treatment with the causative substance does not proceed on that person. For panellists with a "+" or greater response at application times of less than 4 h, it is assumed that they would present a stronger irritant reaction if exposed for 4 h. However, once a "+" or greater response is obtained, there is no need to subject these panellists to further treatment with that substance. In evaluating the results, what is measured is the number of panellists who had a positive "irritant" reaction after a 4-h exposure. If irritation reactions to the undiluted test substance is an significantly greater than or not significantly different (using Fisher\'s exact test) from the level of reaction in that same panel of volunteers to 20% SDS, the substance should be classified as irritant to skin (I); where the level of reaction is substantially and statistically significantly lower than the response to SDS, the substance is not classified (NC) (Basketter *et al.*, [@CIT0006]). Very occasionally, where the response is significantly stronger (and faster to occur), *e.g.* to 0.5% NaOH, then the substance is suggested to be a potential corrosive (C).

In all the above mentioned studies, 20% sodium dodecyl sulfate (SDS) was used as positive control, for reasons that have been well documented (Basketter *et al.* [@CIT0002]; York *et al.*, [@CIT0027]; Robinson *et al.*, [@CIT0022]). A minimum of one third of the panel should react to SDS for the study to be regarded as valid, although exception may be made, *e.g.* when a large proportion of the panel react to the test substance.

Results {#S0004}
=======

The results of the human 4 h patch tests conducted on 81 substances are presented in [Table 1](#T0001){ref-type="table"}, together with their CAS numbers and experimental results. These data have been collated from three main publications (Robinson *et al.*, [@CIT0022]; Basketter *et al.*, [@CIT0007]; Jirova *et al.*, [@CIT0017]). [Table 1](#T0001){ref-type="table"} also reports the proportion of test subjects reacting to the test substance as well as their response to the concurrent 20% SDS positive control. From this information, the final column records how the materials should be classified on the basis of the human response. It is important to mention that use of the positive control in each experiment has compensated for the inevitable variation that occurs beween different human volunteer panels. Furthermore, it has already been demonstrated that the presence of atopicity, and factors such as gender, ethnicity, age, geography and season have no impact on the conclusions drawn from the results (Griffiths *et al.*, [@CIT0016]; Basketter *et al.*, [@CIT0004], [@CIT0005]; McFadden *et al.*, [@CIT0018]; Robinson *et al.*, [@CIT0023], [@CIT0024] [@CIT0022]).

###### 

Materials tested in the human 4 hour patch test.

  No. Test substance   CAS No.                                                             Source of data[1](#TF0001){ref-type="table-fn"}   Known in vivo class                                                                                                           Classification in 4 h HPT[2](#TF0002){ref-type="table-fn"}   4 h HPT positive[3](#TF0003){ref-type="table-fn"}   \% of positive reactions[4](#TF0004){ref-type="table-fn"}   SDS positive[5](#TF0005){ref-type="table-fn"}   
  -------------------- ------------------------------------------------------------------- ------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------ --------------------------------------------------- ----------------------------------------------------------- ----------------------------------------------- -----------
  1                    Acetic acid (10%)                                                   64-19-7                                           Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  6/63                                                        9.5                                             45/64
                       Acetic acid (10%)                                                   64-19-7                                           Robinson *et al.*, [@CIT0022][\*](#TF0007){ref-type="table-fn"}                                                               R38                                                          NC (I)                                              15/46                                                       32.6                                            76/98
  2                    Alcohol ethoxylate C~11~/E3                                         *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  1/32                                                        3.1                                             26/32
  3                    Alcohol ethoxylate C~11~/E7                                         *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  0/31                                                        0                                               12/31
  4                    Alcohol ethoxylate C~12-15~/E3                                      *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  0/32                                                        0                                               24/32
  5                    Alcohol ethoxylate C~12-15~/E5 phosphate                            *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R34                                                          NC                                                  1/32                                                        3.1                                             23/33
  6                    Alcohol ethoxylate C~16-18~/E5                                      *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  0/27                                                        0                                               14/27
  7                    Alcohol ethoxylate C~16-18~/E14                                     *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  0/27                                                        0                                               14/27
  8                    Alkyl dimethyl betaine                                              68424-94-2                                        Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  3/32                                                        9.3                                             12/32
  9                    Alkyl polyglucoside 600                                             *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  1/30                                                        3.3                                             28/31
  10                   Benzalkonium chloride (7.5%)                                        63449-41-2                                        Basketter *et al.*, [@CIT0007] Robinson *et al.*, [@CIT0022] [\*](#TF0007){ref-type="table-fn"}                               R38                                                          I                                                   19/56                                                       33.9                                            32/56
  11                   Benzyl alcohol                                                      100-51-6                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  1/31                                                        3.2                                             17/32
  12                   Benzyl salicylate                                                   118-58-1                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/30                                                        0                                               20/31
  13                   Butan-1-ol                                                          35296-72-1                                        Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  1/31                                                        3.2                                             15/31
  14                   1-Bromo-4-chlorobutane                                              6940-78-9                                         Jirova *et al.*, [@CIT0017]                                                                                                   NC                                                           NC                                                  0/30                                                        0                                               22/30
  15                   1-Bromohexane                                                       111-25-1                                          Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          I                                                   16/30                                                       53.3                                            22/30
  16                   Butyl benzoate                                                      136-60-7                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/30                                                        0                                               14/30
  17                   Butyl methacrylate                                                  97-88-1                                           Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          NC                                                  0/30                                                        0                                               22/30
  18                   Citronellol                                                         106-22-9                                          Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  0/30                                                        0                                               20/31
  19                   Cocotrimethyl ammonium chloride                                     61789-18-2                                        Basketter *et al.*, [@CIT0007] Robinson *et al.*, [@CIT0022] [\*](#TF0007){ref-type="table-fn"}                               R38                                                          NC (I)                                              20/89                                                       22.5                                            50/90
  20                   Decanoic acid                                                       334-48-5                                          Basketter *et al.*, [@CIT0007] Jirova *et al.*, [@CIT0017]                                                                    R38                                                          I                                                   82/110                                                      74.5                                            77/109
  21                   Decanol                                                             112-30-1                                          Basketter *et al.*, [@CIT0007] Jirova *et al.*, [@CIT0017] Robinson *et al.*, [@CIT0022] [\*](#TF0007){ref-type="table-fn"}   R38                                                          NC                                                  25/189                                                      13.2                                            118/189
  22                   N,N-Dimethyl-N-dodecyl aminobetaine                                 *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          I                                                   30/32                                                       93.8                                            27/32
  23                   3,4-Dimethyl-1H-pyrazole                                            2820-37-3                                         Jirova *et al.*, [@CIT0017]                                                                                                   NC                                                           NC (I)                                              11/29                                                       37.9                                            26/29
  24                   Dimethylsulfoxide                                                   67-68-5                                           Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           I                                                   31/31                                                       100                                             12/31
  25                   Dodecanoic acid                                                     143-07-7                                          Basketter *et al.*, [@CIT0007]; Jirova *et al.*, [@CIT0017]                                                                   R38                                                          NC                                                  4/90                                                        4.4                                             65/91
  26                   Dodecanol                                                           112-53-8                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/29                                                        0                                               16/29
  27                   Ethylenediamine tetraacetic acid disodium salt                      139-33-3                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/26                                                        0                                               21/26
  28                   Ethanol                                                             64-17-5                                           Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  1/31                                                        3.2                                             15/31
  29                   Eugenol                                                             97-53-0                                           Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  4/26                                                        15.3                                            21/26
  30                   Geraniol                                                            106-24-1                                          Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  5/28                                                        17.9                                            23/30
  31                   Heptanal                                                            111-71-7                                          Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          I                                                   17/29                                                       58.6                                            23/29
  32                   Heptanoic acid                                                      111-14-8                                          Basketter *et al.*, [@CIT0007]                                                                                                R34                                                          I                                                   20/31                                                       64.5                                            20/31
  33                   Heptyl butyrate                                                     5870-93-9                                         Basketter *et al.*, [@CIT0007] Jirova *et al.*, [@CIT0017]                                                                    NC                                                           NC                                                  0/60                                                        0                                               40/61
  34                   Hexadecanoic acid                                                   57-10-3                                           Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/29                                                        0                                               22/31
  35                   Hexanol                                                             111-27-3                                          Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC (I)                                              8/28                                                        28.6                                            21/28
                       Hexanol                                                             111-27-3                                          Robinson *et al.*, [@CIT0022][\*](#TF0007){ref-type="table-fn"}                                                               R38                                                          NC                                                  10/59                                                       16.9                                            48/58
  36                   Hexyl salicylate                                                    6259-76-3                                         Basketter *et al.*, [@CIT0007] Jirova *et al.*, [@CIT0017]                                                                    R38                                                          NC                                                  0/60                                                        0                                               38/60
  37                   Hydrochloric acid (10%)                                             7647-01-0                                         Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  16/89                                                       18.0                                            49/91
  38                   Hydrogenated tallow amine                                           61788-45-2                                        Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          I                                                   19/19                                                       100                                             17/19
  39                   Hydroxycitronellal                                                  89-43-0                                           Jirova *et al.*, [@CIT0017]                                                                                                   NC                                                           NC                                                  0/30                                                        0                                               22/30
  40                   Isopropanol                                                         67-63-0                                           Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/31                                                        0                                               17/32
  41                   2-Isopropyl-2-isobutyl-1,3-dimethoxypropane                         129228-21-3                                       Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          NC (I)                                              6/29                                                        20.7                                            26/29
  42                   Isopropyl myristate                                                 110-27-0                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  1/30                                                        3.3                                             18/31
  43                   Isopropyl palmitate                                                 142-91-6                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/29                                                        0                                               17/29
  44                   1-(2-Isopropylphenyl)-1-phenylethane (Mixture of isomers)           191044-60-7                                       Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          NC                                                  0/29                                                        0                                               26/29
  45                   Lactic acid                                                         50-21-5                                           Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          I/C                                                 21/26                                                       80.8                                            15/25
  46                   Linalyl acetate                                                     115-95-7                                          Basketter *et al.*, [@CIT0007]/15                                                                                             R38                                                          NC                                                  1/61                                                        1.6                                             35/61
  47                   Methyl caproate                                                     106-70-7                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/29                                                        0                                               17/29
  48                   Bis\[(1-Methylimidazol)-(2- ethyl-hexanoate)\], zinc complex        not allocated                                     Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          NC                                                  0/29                                                        0                                               26/29
  49                   Methyl laurate                                                      111-82-0                                          Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  0/31                                                        0                                               15/31
  50                   Methyl palmitate                                                    112-39-0                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  1/29                                                        3.5                                             17/29
  51                   4-Methylthio benzaldehyde                                           3446-89-7                                         Jirova *et al.*, [@CIT0017]                                                                                                   NC                                                           NC                                                  0/30                                                        0                                               22/30
  52                   1-Naphthalene acetic acid                                           86-87-3                                           Jirova *et al.*, [@CIT0017]                                                                                                   NC                                                           NC                                                  0/30                                                        0                                               22/30
  53                   Nonanoic acid                                                       112-05-0                                          Jirova *et al.*, [@CIT0017]                                                                                                   R34/R38                                                      I                                                   19/29                                                       65.5                                            26/29
  54                   Octanol                                                             111-87-5                                          Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  5/28                                                        17.9                                            21/28
                       Octanol                                                             111-87-5                                          Robinson *et al.*, [@CIT0022][\*](#TF0007){ref-type="table-fn"}                                                               R38                                                          NC                                                  9/55                                                        16.4                                            48/58
  55                   Octanoic acid                                                       124-07-2                                          Basketter *et al.*, [@CIT0007]                                                                                                R34                                                          I                                                   48/63                                                       76.2                                            38/62
  56                   n-Pentanol                                                          71-41-0                                           Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/30                                                        0                                               14/30
  57                   Polyethylene glycol 400                                             25322-68-3                                        Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/28                                                        0                                               12/28
  58                   di-n-Propyl disulfide                                               629-19-6                                          Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          NC                                                  6/30                                                        20                                              22/30
  59                   di-Propylene glycol                                                 25265-71-8                                        Jirova *et al.*, [@CIT0017]                                                                                                   NC                                                           NC                                                  0/30                                                        0                                               22/30
  60                   Propylene glycol tertiary butyl ether                               57018-52-7                                        Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/28                                                        0                                               12/28
  61                   Potassium soap                                                      8046-74-0                                         Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/31                                                        0                                               9/29
  62                   C~12-13~ beta-branched primary alcohol sulfate/1-ethoxylate         *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC (I)                                              9/30                                                        30                                              28/31
  63                   C~12-13~ beta-branched primary alcohol sulfate                      *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          I                                                   26/31                                                       83.9                                            28/31
  64                   Propylene glycol                                                    57-55-6                                           Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  2/32                                                        6.25                                            23/33
  65                   Sodium carbonate                                                    497-19-8                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/26                                                        0                                               21/26
  66                   Sodium dodecyl sulphate (20%)                                       151-21-3                                          Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          I                                                   54/65                                                       83.1                                            137/182
                       Sodium dodecyl sulphate (20%)                                       151-21-3                                          Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          I                                                   94/118                                                      79.7                                            94/118
                       Sodium dodecyl sulphate (20%)                                       151-21-3                                          Robinson *et al.*, [@CIT0022][\*](#TF0007){ref-type="table-fn"}                                                               R38                                                          I                                                   817/1154                                                    70.8                                            1154/1154
                       Sodium dodecyl sulphate (10%)                                       151-21-3                                          Robinson *et al.*, [@CIT0022][\*](#TF0007){ref-type="table-fn"}                                                               R38                                                          NC (I)                                              203/295                                                     68.8                                            239/292
                       Sodium dodecyl sulphate (1%)                                        151-21-3                                          Robinson *et al.*, [@CIT0022][\*](#TF0007){ref-type="table-fn"}                                                               R38                                                          NC (I)                                              52/231                                                      22.5                                            196/229
  67                   Sodium hydroxide (0.5%)                                             1310-73-2                                         Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          I/C                                                 20/33^5^                                                    60.6^5^                                         23/33^5^
                       Sodium hydroxide (0.5%)                                             1310-73-2                                         Robinson *et al.*, [@CIT0022][\*](#TF0007){ref-type="table-fn"}                                                               R38                                                          I/C                                                 57/98^5^                                                    58.2                                            12/98^5^
  68                   Sodium percarbonate                                                 15630-89-4                                        Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  1/26                                                        3.8                                             21/26
  69                   Sodium perborate                                                    7632-04-4                                         Basketter *et al.*, [@CIT0007]                                                                                                R38                                                          NC                                                  1/26                                                        3.9                                             21/26
  70                   Sodium soap                                                         *not allocated*                                   Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/31                                                        0                                               9/29
  71                   Sodium xylene sulfonate                                             1300-72-7                                         Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/30                                                        0                                               16/30
  72                   1-(Spiro\[4.5\]dec-7-en-7-yl)pent-4-en-1-one (mixture of isomers)   224031-70-3                                       Jirova *et al.*, [@CIT0017]                                                                                                   NC                                                           NC                                                  0/29                                                        0                                               26/29
  73                   a-Terpineol                                                         98-55-5                                           Basketter *et al.*, [@CIT0007]/15                                                                                             R38                                                          NC                                                  0/59                                                        0                                               39/59
  74                   Terpinyl acetate                                                    80-26-2                                           Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          NC                                                  0/30                                                        0                                               22/30
  75                   Tetradecanoic acid                                                  544-63-8                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/29                                                        0                                               22/31
  76                   Tetradecanol                                                        112-72-1                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/29                                                        0                                               16/29
  77                   Triethanolamine                                                     102-71-6                                          Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  0/32                                                        0                                               26/32
  78                   Tris(hydroxymethyl)aminomethane                                     77-86-1                                           Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  2/32                                                        6.2                                             12/32
  79                   Tween 80                                                            9005-65-6                                         Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  1/29                                                        3.5                                             24/29
                       Tween 80                                                            9005-65-6                                         Robinson *et al.*, [@CIT0022][\*](#TF0007){ref-type="table-fn"}                                                               NC                                                           NC                                                  2/53                                                        3.8                                             32/56
  80                   10-Undecenoic acid                                                  112-38-9                                          Jirova *et al.*, [@CIT0017]                                                                                                   R38                                                          NC                                                  1/29                                                        3.5                                             23/29
  81                   Water                                                               7732-18-5                                         Basketter *et al.*, [@CIT0007]                                                                                                NC                                                           NC                                                  3/59                                                        5.8                                             58/59

Reference source for the original data and classifications

Classification of a substance in 4 h HPT based on established prediction model

Number of individuals with a positive irritant reaction to the test material/total panel size

Percentage of positive responses to substance independently of SDS

Number of individuals with a positive irritant reaction to the 20% SDS control in the same panel

Number of positive reactions after exposure only up to 1h

Results from multi-laboratory study (two and more laboratories)

R34-Corrosive, R38-Irritant, NC- not classified; I- Irritant in human, I/C -- Irritant possibly corrosive

NC (I) - possible introduction of a provision that where \>20% of the panel are positive to the test substance independently of the response to SDS, the substance may be considered as irritant.

Based on *in vivo* rabbit tests, more than 50% of chemicals are classified as irritants in [Table 1](#T0001){ref-type="table"} (Robinson *et al.*, [@CIT0022]; Basketter *et al.*, [@CIT0007]; Jirova *et al.*, [@CIT0017]), wheras in the human patch test, using the classification critiera described earlier, only about 20% of the substances tested were identified as human irritants, with two possible corrosive classifications (\#45 Lactic Acid; \#67 0.5% Sodium Hydroxide).

In the current study, 7 substances, namely: \#1 Acetic acid, \#19 Cocotrimethyl ammonium chloride, \#23 3,4-Dimethyl-1H-pyrazole, \#35 hexanol, \#41 2- Isopropyl-2-isobutyl-1,3-dimethoxypropane. \#43 C~12-13~ ~beta-branched~ primary alcohol sulfate/1-ethoxylate, \#66 Sodium dodecyl sulphate at concentrations of 10% and 1%, provided significant irritating response in more than 20% of panelists, as is indicated in [Table 1](#T0001){ref-type="table"}. Additional precautionary principle, that positive classification would be assigned if more than 20% of the panel reacted on the test substance, could be applied in this situation to avoid false negative results.

Discussion {#S0005}
==========

Regulatory relevance of human data {#S20006}
----------------------------------

According to the European CLP Regulation (Commission Regulation, [@CIT0009]), classification of any substance or mixture should preferably be generated in accordance with the test methods referred in Regulation (EC) No. 1907/2006, *i.e.* Council Regulation (EC) No. 440/2008 or OECD Guidelines. However, the CLP Regulation at the same time stipulates in the Recital 20--21 and Article 7.3, that data obtained from other sources, such as clinical studies, can be used for the purpose of the CLP Regulation (ECHA, [@CIT0012]). Classification should be carried out on the basis of all relevant information on the hazards of the substance or mixture and there is an obligation to evaluate the quality of all available information.

It is important to keep in mind that the classification of a substance as irritant in existing *in vivo* protocols used for regulatory toxicology purposes reflects only a significant potential of substance for the production of an acute irritant effect. The cumulative irritant capability of a substance is not taken into account. Regulatory decision not to classify a substance, mixture or formulation does not by any means imply that the product is entirely free of any skin irritation potential, only that the level of irritant activity is likely not sufficient to trigger classification.

Although it is not allowed to test substances on humans for the purpose of CLP Regulation, the manufacturer, importer or downstream user should, for the purpose of classification, take into account all human data available, such as epidemiological studies on exposed populations, accidental or occupational exposure data, and clinical studies. That information should be compared with the criteria for the different hazard classes and differentiations, so that the manufacturer, importer or downstream user can arrive at a conclusion as to whether or not the substance or mixture should be classified as hazardous.

Reflecting on results presented in [Table 1](#T0001){ref-type="table"}, the current classification decision strategy based on human 4 h patch test states that substance whose irritant capacity is significantly less than 20% SDS should not be classified. However, this conclusion might require some reconsideration. Under conditions, where a panel of volunteers is large and the statistical significance of Fisher′s exact test and final classification may be influenced, the provision could be included, that positive classification would normally occure if more than 20% of panellist reacted to the test substance, also considering the precautional principle for later accidental exposure in humans. In this case, a recommended number of panellists involved in the study should be defined.

The quality and relevance of existing human data for hazard assessment should always be critically reviewed. There may be a significant level of uncertainty in existing human data due to poor reporting and lack of specific information on exposure. Diagnosis confirmed by expert physicians may be missing. Confounding factors may not have been accounted for. Small group sizes may flaw the statistical strength of evidence and many other factors may compromise the validity of human data. In clinical and scientific studies the selection of individuals for the test and the control groups must be carefully considered. Any clinical studies may however contribute to the weight of evidence assessment with other available information such as existing data from animal or other experimental studies.

Importantly, when human data demonstrate hazards that have not been identified by animal studies, the animal results should be weighed against human data and expert judgement should be used to ensure the best protection of human health when evaluating both the animal and human data, as specified in Recital 28 of the CLP Regulation. Actually, the available data indicate that human skin is, in most cases, less sensitive than that of rabbits (Phillips *et al.*, [@CIT0020]; Nixon *et al.*, [@CIT0019]; Campbell & Bruce, [@CIT0008]).

A critical review of the value of human studies is provided in IR/CSA Section R.4.3.3 and more specific considerations for the skin corrosion/irritation endpoint are given in IR/CSA Section R.7.2.4.2. IR/CSA Guidance on Information Requirements and Chemical Safety Assessment, ECHA, 2008 (<http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm>).

Use of human data for development of relevant *in vitro* assays {#S20007}
---------------------------------------------------------------

*In vitro* alternatives for the identification of skin irritation have been the subject of investigation and development in a considerable number of laboratories for many years (reviewed in Eskes *et al.*, [@CIT0014]; Welss *et al.*, [@CIT0026]; Gibbs, [@CIT0015]), and these are now broadly accepted by regulatory authorities (ECHA, [@CIT0013]; Commission Regulation, [@CIT0009]). These alternatives were established to recapitulate the results previously obtained from *in vivo* rabbit studies, which are very sensitive, however they poorly reflect human exposure scenarios and thus also human hazard (Phillips *et al.*, [@CIT0020]; Nixon *et al.*, [@CIT0019]; Campbell & Bruce, [@CIT0008]).

Clinically, skin irritation is a type of dermatitis whose causation is complex and which involves repeated exposures to a range of noxious stimuli. Skin corrosion, where substances can cause burns and irreverisble damage is a much more clear cut situation. Because of the intensity of the skin responses to corrosive substances and the irreversibility of effects, correct prediction of corrosive effect is of great importance. Thus, incorrect classification of corrosive substances, either by the *in vivo* rabbit assay or by *in vitro* methods established on the rabbit based classification, remains a cause of some concern.

The data presented in [Table 1](#T0001){ref-type="table"} offer results with 81 substances which can be used to assess the ability of *in vitro* methods to predict accurately the acute skin irritation and corrosion potential of a range of substances. The results include two substances, lactic acid and 0.5% sodium hydroxide, which based on rabbit data were not thought to be potentially corrosive, but for which the results of the human study suggest corrosive classification. Correct classification of lactic acid and NaOH including their dilutions is of specific importance as they are used as ingredients in consumer products (cosmetics) for keratolytic purposes. It is of concern whether keratolysis based on skin corrosive effect for cosmetic purposes should be generally acceptable.

Conclusion {#S0008}
==========

The retrospective evaluation of existing human data presented in this paper provides n unique opportunity to compare data on skin irritation hazard classification obtained with classic regulatory acccepted methods (*i.e.* the *in vivo* rabbit skin irritation test) with human data on hazard, with the ultimate aim to enhance the accuracy of the information on hazard contained in manufacturers' safety data sheets. The information presented in [Table 1](#T0001){ref-type="table"} can and should be used to develop alternative methods that provide classification and labelling that is most relevant to the true human hazard.
